drugset / Trial / NCT04374591

The Role of Sodium Bicarbonate as Adjuvant Treatment of Computed Tomography Identified COVID-19 Pneumonia

NCT04374591

Unknown 180 enrolled Mansoura University
Non-randomizedParallel-groupOpen-labelTreatment

Summary

To report the possible role of S.B 8.4% in the treatment of COVID-19pneumonia.

Timeline

Start
2020-08-01
Primary completion
2020-11-01
Completion
2020-11-01

Drugs

EvaluationDrugModalityDoseRoute
Subject sodium bicarbonate Diagnostic / imaging agent 8.4 % Inhaled

Indications